These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 22990561

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Refractory anaemia with ringed sideroblasts associated with marked thrombocytosis (RARS-T) with superimposed 5q-syndrome.
    Ziarkiewicz M, Dwilewicz-Trojaczek J, Pastwińska A, Chmarzyńska E, Paszkowska-Kowalewska M, Koperski Ł, Jędrzejczak WW, Ziarkiewicz-Wróblewska B.
    Pol J Pathol; 2010; 61(2):105-9. PubMed ID: 20924996
    [Abstract] [Full Text] [Related]

  • 6. Occurrence of the JAK2 V617F mutation in the WHO provisional entity: myelodysplastic/myeloproliferative disease, unclassifiable-refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
    Remacha AF, Nomdedéu JF, Puget G, Estivill C, Sarda MP, Canals C, Aventin A.
    Haematologica; 2006 May; 91(5):719-20. PubMed ID: 16670082
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
    Schmitt-Graeff AH, Teo SS, Olschewski M, Schaub F, Haxelmans S, Kirn A, Reinecke P, Germing U, Skoda RC.
    Haematologica; 2008 Jan; 93(1):34-40. PubMed ID: 18166783
    [Abstract] [Full Text] [Related]

  • 9. Refractory anemia with ring sideroblasts and RARS with thrombocytosis.
    Patnaik MM, Tefferi A.
    Am J Hematol; 2015 Jun; 90(6):549-59. PubMed ID: 25899435
    [Abstract] [Full Text] [Related]

  • 10. Is refractory anaemia with ring sideroblasts and thrombocytosis (RARS-T) a necessary or useful diagnostic category?
    Wardrop D, Steensma DP.
    Br J Haematol; 2009 Mar; 144(6):809-17. PubMed ID: 19120370
    [Abstract] [Full Text] [Related]

  • 11. Refractory anemia with ring sideroblasts.
    Malcovati L, Cazzola M.
    Best Pract Res Clin Haematol; 2013 Dec; 26(4):377-85. PubMed ID: 24507814
    [Abstract] [Full Text] [Related]

  • 12. Refractory anemia with ringed sideroblasts associated with thrombocytosis: comparative analysis of marked with non-marked thrombocytosis, and relationship with JAK2 V617F mutational status.
    Raya JM, Arenillas L, Domingo A, Bellosillo B, Gutiérrez G, Luño E, Piñán MA, Barbón M, Pérez-Sirvent ML, Muruzábal MJ, Yánez L, García L, Lemes A, Navarro JT, Elosegi A, Cortés MA, Villegas A, Durán MA, Ardanaz M, Florensa L, Grupo Español de Citología Hematológica (GECH), Working Group into the Asociación Española de Hematología y Hemoterapia (AEHH).
    Int J Hematol; 2008 Nov; 88(4):387-395. PubMed ID: 18820995
    [Abstract] [Full Text] [Related]

  • 13. A case of refractory anemia with ring sideroblasts and associated thrombocytosis.
    Issa S, Ingley K.
    Blood; 2013 May 23; 121(21):4256. PubMed ID: 23844433
    [No Abstract] [Full Text] [Related]

  • 14. Development of refractory anemia with ring sideroblasts associated with thrombocytosis from pre-existing refractory anemia with ring sideroblasts through acquisition of Jak2 V617F mutation.
    Lu CM, Zhou L, Wang E, Feng S, Sebastian S, Behler C.
    Leuk Lymphoma; 2011 Dec 23; 52(12):2405-7. PubMed ID: 21806348
    [No Abstract] [Full Text] [Related]

  • 15. Revisiting diagnostic criteria for myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Borderline cases without anemia exist.
    Li P, Shahmarvand N, Lynch D, Gotlib JR, Merker JD, Zehnder JL, George TI, Ohgami RS.
    Int J Lab Hematol; 2019 Jun 23; 41(3):345-352. PubMed ID: 30811101
    [Abstract] [Full Text] [Related]

  • 16. Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis: "2019 Update on Diagnosis, Risk-stratification, and Management".
    Patnaik MM, Tefferi A.
    Am J Hematol; 2019 Apr 23; 94(4):475-488. PubMed ID: 30618061
    [Abstract] [Full Text] [Related]

  • 17. Age, JAK2(V617F) and SF3B1 mutations are the main predicting factors for survival in refractory anaemia with ring sideroblasts and marked thrombocytosis.
    Broséus J, Alpermann T, Wulfert M, Florensa Brichs L, Jeromin S, Lippert E, Rozman M, Lifermann F, Grossmann V, Haferlach T, Germing U, Luño E, Girodon F, Schnittger S, MPN and MPNr-EuroNet (COST Action BM0902).
    Leukemia; 2013 Sep 23; 27(9):1826-31. PubMed ID: 23594705
    [Abstract] [Full Text] [Related]

  • 18. Thrombocytosis with sideroblastic erythropoiesis: a mixed myeloproliferative myelodysplastic syndrome.
    Gupta R, Abdalla SH, Bain BJ.
    Leuk Lymphoma; 1999 Aug 23; 34(5-6):615-9. PubMed ID: 10492088
    [Abstract] [Full Text] [Related]

  • 19. [Chronic myelomonocytic leukemia transformed from refractory anemia with ring sideroblasts with a rare abnormal chromosome, inv (12)].
    Hasegawa Y, Sakai N, Toyama M, Ninomiya H, Abe T.
    Rinsho Ketsueki; 1990 Jan 23; 31(1):75-9. PubMed ID: 2179602
    [Abstract] [Full Text] [Related]

  • 20. Myelodysplastic/myeloproliferative neoplasms.
    Cazzola M, Malcovati L, Invernizzi R.
    Hematology Am Soc Hematol Educ Program; 2011 Jan 23; 2011():264-72. PubMed ID: 22160044
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.